Get started
Author

Anshu Thakur

Observed name: A. Thakur
ORCID: 0000-0002-4824-7673
Observed ORCID: 0000-0002-4824-7673
OpenAlex ID: A5103113010
A systemic review and meta-analysis of Aflibercept plus FOLFIRI regimen as a second-line treatment for metastatic colorectal cancer: A PRISMA compliant pooled analysis of randomized controlled trials and single arm studies to assess efficacy and safety
2023 · Anshu Thakur, Mehul R. Chorawala, et al. · Critical Reviews in Oncology/Hematology · 11
Kaempferol as a potent sensitizer for 5-fluorouracil (5-FU) to boost therapeutic index in colorectal cancer therapy
2025 · Abhilasha Sharma, Anshu Thakur, et al. · Food Bioscience · 3
The evolving landscape of cancer cachexia prevention: A review of metronomic chemotherapy and drug repurposing strategies
2025 · Anshu Thakur, Mehul R. Chorawala · Medical Oncology · 2
The role of rivaroxaban in the management of coronary artery disease: an overview of five landmark clinical trials
2025 · Anshu Thakur, Mehul R. Chorawala · Naunyn-Schmiedeberg s Archives of Pharmacology
Conquering cardiotoxicity of trastuzumab: A 99Tc radiolabelled bio-distribution study
2017 · A. Thakur, V. Dhote · Annals of Oncology
Drug delivery of trastuzumab to bypass the associated cardiotoxicty-A 99Tc radiolabelled bio-distribution study
2017 · A. Thakur, V. Dhote · Annals of Oncology
PDF
Works count: 6
Citation count: 16
H-index: 2
I10-index: 1
Year
Topic
Type